alloxan has been researched along with Chronic Disease in 9 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined the changes in blood-brain barrier (BBB) permeability following acute aluminum (Al) exposure during acute and chronic hyperglycemia in rats." | 3.71 | Effect of aluminum on the blood-brain barrier permeability in acute and chronically hyperglycemic rats. ( Cevik, A; Elmas, I; Kalayci, RB; Kaya, M; Kücük, M, 2001) |
| "Chronic wounds are among the most devastating and difficult to treat consequences of diabetes." | 1.48 | Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds. ( Abadir, P; Ansari, A; Berger, A; Beselman, A; Budman, J; Faghih, M; Fedarko, N; Harmon, J; Hosseini, S; Inagami, T; Keenahan, K; Lay, F; Marti, G; Rini, D; Smith, B; Tian, J; Vuong, D; Walston, J, 2018) |
| "Anxiety, fear, and anhedonia are mediated by interactions between different deep structures of the temporal lobe (e." | 1.43 | Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia. ( Contreras, CM; Guillén-Ruiz, G; Gutiérrez-García, AG; Moreno-Cortés, ML; Romo-González, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abadir, P | 1 |
| Hosseini, S | 1 |
| Faghih, M | 1 |
| Ansari, A | 1 |
| Lay, F | 1 |
| Smith, B | 1 |
| Beselman, A | 1 |
| Vuong, D | 1 |
| Berger, A | 1 |
| Tian, J | 1 |
| Rini, D | 1 |
| Keenahan, K | 1 |
| Budman, J | 1 |
| Inagami, T | 1 |
| Fedarko, N | 1 |
| Marti, G | 1 |
| Harmon, J | 1 |
| Walston, J | 1 |
| Lucchesi, AN | 2 |
| Freitas, NT | 1 |
| Cassettari, LL | 2 |
| Marques, SF | 1 |
| Spadella, CT | 2 |
| Moreno-Cortés, ML | 1 |
| Gutiérrez-García, AG | 1 |
| Guillén-Ruiz, G | 1 |
| Romo-González, T | 1 |
| Contreras, CM | 1 |
| Choinowski, S | 1 |
| Hecht, K | 1 |
| Baumann, R | 1 |
| Baĭteriakova, LS | 1 |
| Koretskaia, IuM | 1 |
| Kücük, M | 1 |
| Kalayci, RB | 1 |
| Cevik, A | 1 |
| Elmas, I | 1 |
| Kaya, M | 1 |
| Spivak, AM | 1 |
| Reĭngardt, VK | 1 |
| Galetskaia, TM | 1 |
| Liashko, NA | 1 |
| Litinskaia, EV | 1 |
| Brookshire, KH | 1 |
9 other studies available for alloxan and Chronic Disease
| Article | Year |
|---|---|
Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds.
Topics: Administration, Cutaneous; Alloxan; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting | 2018 |
Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease.
Topics: Alloxan; Animals; Biomarkers; Chronic Disease; Diabetes Mellitus, Experimental; Liver; Liver Disease | 2013 |
Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans.
Topics: Alanine Transaminase; Alloxan; Animals; Aspartate Aminotransferases; Body Weight; Cell Nucleus; Chro | 2015 |
Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia.
Topics: Alloxan; Amygdala; Anhedonia; Animals; Anxiety; Chronic Disease; Dietary Sucrose; Disease Models, An | 2016 |
The importance of individual excitability of the CNS for the production of alloxan diabetes and its influence on central nervous functional state.
Topics: Acute Disease; Alloxan; Animals; Central Nervous System; Chronic Disease; Conditioning, Classical; D | 1967 |
[Clinical morphological studies of the organ of vision in experimental alloxan diabetes].
Topics: Alloxan; Animals; Chronic Disease; Diabetes Mellitus, Experimental; Eye; Fundus Oculi; Rabbits | 1980 |
Effect of aluminum on the blood-brain barrier permeability in acute and chronically hyperglycemic rats.
Topics: Acute Disease; Alloxan; Aluminum; Animals; Blood-Brain Barrier; Chronic Disease; Coloring Agents; Ev | 2001 |
[Comparative evaluation of the therapeutic effect of oxyferriscorbone in peptic ulcer].
Topics: 2,3-Diketogulonic Acid; Adolescent; Adult; Alloxan; Anti-Ulcer Agents; Chronic Disease; Drug Combina | 1985 |
Changes in the rats preference for saccharin and sodium chloride solutions following injection of alloxan monohydrate.
Topics: Age Factors; Alloxan; Animals; Appetite; Avoidance Learning; Blood Glucose; Body Weight; Chronic Dis | 1974 |